ARTICLE | Clinical News
Phenoxodiol (NV-06): Began Phase I trial
January 16, 2001 8:00 AM UTC
Novogen Ltd. (NVGN; ASX:NRT), Sydney, Australia Product: Phenoxodiol ( NV-06) Business: Cancer Therapeutic category: Cell proliferation, Apoptosis Target: Topoisomerase, tyrosine kinase and other enz...